COMMUNIQUÉS West-GlobeNewswire

Inmagene Announces Completion of Enrollment in Phase 2a Trial of IMG-007, a Nondepleting and Half-life Extended Anti-OX40 Monoclonal Antibody, in Patients with Alopecia Areata
07/05/2024
IMG-007, the only clinical-stage nondepleting anti-OX40 monoclonal antibody (mAb), is being evaluated in adult patients with alopecia areata (AA) and atopic dermatitis (AD). The enrollment of the Phase 2a study in AA [...]
T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease
07/05/2024
Advances plan to launch T2Lyme Panel for detection of early Lyme disease Filed Pursuant to Rule 433 Issuer Free Writing Prospectus dated May 6, 2024 Relating to Preliminary Prospectus dated May 6, 2024 Registration No. [...]
Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2024 Annual General Meeting
07/05/2024
Information relating to the holding of the Combined Shareholders’ Meeting of 28 May 2024 of Ipsen S.A. Formalities for making available and consulting preparatory documents to the Meeting BOULOGNE-BILLANCOURT, FRANCE, 7 [...]
IPSEN SA. - Modalités de mise à disposition et de consultation des documents préparatoires à l’Assemblée Générale Mixte du 28 mai 2024
07/05/2024
Informations concernant la tenue de l’Assemblée Générale Mixte du 28 mai 2024 d’Ipsen S.A. Modalités de mise à disposition et de consultation des documents préparatoires à l’Assemblée BOULOGNE-BILLANCOURT, FRANCE, 7 mai [...]
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa
07/05/2024
Cannabix is developing alcohol and marijuana breathalyzer devices to give law enforcement and employers a tool to enhance public safety VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies [...]
Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights
07/05/2024
- Interim data from SEAPORT-1, a Phase 1 trial of INZ-701 in patients with end-stage kidney disease receiving hemodialysis, on track for fourth quarter of 2024 - - Interim data from ENERGY-1, a Phase 1b trial of INZ-701 [...]
Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
07/05/2024
Company to host conference call to discuss financial results and provide a corporate update on May 13, 2024 at 4:30 p.m. ET SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey [...]
Scorpius Holdings Appoints New VP of Business Development Shari Udoff-McDonald
07/05/2024
Biopharma industry veteran joins Scorpius’ leadership team DURHAM, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc. (NYSE American: SCPX) (“Scorpius” or the “Company”), an integrated contract development [...]
Palisade Bio Appoints Margery Fischbein to its Board of Directors
07/05/2024
Wall Street and biotech industry veteran with expertise across corporate finance, business development, M&A, licensing, and strategic alliance transactions, globally Carlsbad, CA, May 07, 2024 (GLOBE NEWSWIRE) -- [...]
IMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business
07/05/2024
FRANKLIN, Tenn., May 07, 2024 (GLOBE NEWSWIRE) -- On May 1, 2024, as previously announced, pursuant to that certain Settlement and Release Agreement, by and between IMAC Holdings, Inc. (NASDAQ: BACK) (“BACK”) and [...]
Femasys Expands Commercial Management Team with Addition of Experienced New Hires
07/05/2024
Team to Drive Strategic Initiatives, Launching Efforts at 2024 ACOG Meeting ATLANTA, May 07, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet [...]
Nanox to Participate in Three Upcoming Investor Conferences in May 2024
07/05/2024
PETACH TIKVA, Israel, May 07, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announces that Company management will [...]
Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference
07/05/2024
CAMBRIDGE, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today [...]
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy
07/05/2024
TARRYTOWN, New York, May 07, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica , Inc. (OTC: PXMD ), a biopharmaceutical company focused on advancing treatments for neurological disorders, provided a corporate update in [...]
BrightInsight Expands its Partnership with Google Cloud to Enhance the Patient Journey Through Generative AI
07/05/2024
BrightInsight is modernizing its development processes and patient companion apps with Google’s Gemini models, MedLM, and Vertex AI SAN JOSE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- BrightInsight, Inc, the trusted [...]
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
07/05/2024
WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet [...]
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
07/05/2024
The eAArly DETECT results reported a sensitivity for colorectal cancer of 97% with a specificity of 97% and a sensitivity for advanced adenoma of 82% BERKELEY, Calif. and MAINZ, Germany, May 07, 2024 (GLOBE NEWSWIRE [...]
Creyon Bio to Present Clinical Data on Rapid AI-Enabled Engineering of Oligonucleotide-Based Medicines at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
07/05/2024
AI-informed drug design enabled approval to dose within one year of project initiation Data highlight use of AI to engineer investigative allele selective antisense oligonucleotide treatment for baby with ultra-rare [...]
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
07/05/2024
Encouraging preliminary data announced from the NXP800 Phase 1b study in platinum resistant, ARID1a-mutated ovarian cancer, a program granted Fast Track Designation by the US FDA Data presented at the 2024 AACR [...]

Pages